Reply

We thank Rossi et  al for commenting on our study supporting adherence to the American Academy of Pediatrics (AAP) recommendations for palivizumab prophylaxis among children at ≥29 and 

Source: The Journal of Pediatrics - June 12, 2019 Category: Pediatrics Authors: Tracy N. Zembles, Glenn Bushee, Rodney E. Willoughby Tags: Letters to the Editor Source Type: research